What’s a potential medical breakthrough without a little controversy? Resia Pretorius Ph.D., a South African researcher from the Stellenbosch University in South Africa, and her colleague Douglas Kell from the University of Liverpool, UK, are right in the thick...
Suzanne Vernon’s interest in pathogens and post-infectious diseases goes back to when, as a 20-year-old, she landed a work-study job at the CDC’s Division of Vector-Borne Diseases while an undergraduate at Colorado State University. Ten years later with...
It’s nice to have a billionaire in your corner. Earlier this year, billionaire Vitalik Buterin pledged to devote $100 million to high-risk, high-reward COVID-19 efforts. He made good on at least $15 million of that when he jumpstarted The Long COVID...
One of the first questions that could be answered regarding long COVID quite quickly is why it’s happening. Why did one person not recover when so many others did? That question has bedeviled many people with chronic fatigue syndrome (ME/CFS), post-infectious...
Friendly Fire? Recent studies featuring potentially game-changing blood vessel problems in ME/CFS/FM and long COVID have been illuminating but have lacked a crucial component: how it all started. A July study led by Edward Yang and fellow Yale researchers published in...
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.